These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 30600358)

  • 21. Revisiting autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE) mutations in the nicotinic acetylcholine receptor reveal an increase in efficacy regardless of stochiometry.
    Indurthi DC; Qudah T; Liao VW; Ahring PK; Lewis TM; Balle T; Chebib M; Absalom NL
    Pharmacol Res; 2019 Jan; 139():215-227. PubMed ID: 30472464
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Attenuation of nicotine taking and seeking in rats by the stoichiometry-selective alpha4beta2 nicotinic acetylcholine receptor positive allosteric modulator NS9283.
    Maurer JJ; Sandager-Nielsen K; Schmidt HD
    Psychopharmacology (Berl); 2017 Feb; 234(3):475-484. PubMed ID: 27844094
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Augmentation of cognitive function by NS9283, a stoichiometry-dependent positive allosteric modulator of α2- and α4-containing nicotinic acetylcholine receptors.
    Timmermann DB; Sandager-Nielsen K; Dyhring T; Smith M; Jacobsen AM; Nielsen EØ; Grunnet M; Christensen JK; Peters D; Kohlhaas K; Olsen GM; Ahring PK
    Br J Pharmacol; 2012 Sep; 167(1):164-82. PubMed ID: 22506660
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Concatemers to re-investigate the role of α5 in α4β2 nicotinic receptors.
    Prevost MS; Bouchenaki H; Barilone N; Gielen M; Corringer PJ
    Cell Mol Life Sci; 2021 Feb; 78(3):1051-1064. PubMed ID: 32472188
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessing potentiation of the (α4)3(β2)2 nicotinic acetylcholine receptor by the allosteric agonist CMPI.
    Deba F; Munoz K; Peredia E; Akk G; Hamouda AK
    J Biol Chem; 2022 Jan; 298(1):101455. PubMed ID: 34861241
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Orthosteric and allosteric potentiation of heteromeric neuronal nicotinic acetylcholine receptors.
    Wang J; Lindstrom J
    Br J Pharmacol; 2018 Jun; 175(11):1805-1821. PubMed ID: 28199738
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Additional acetylcholine (ACh) binding site at alpha4/alpha4 interface of (alpha4beta2)2alpha4 nicotinic receptor influences agonist sensitivity.
    Mazzaferro S; Benallegue N; Carbone A; Gasparri F; Vijayan R; Biggin PC; Moroni M; Bermudez I
    J Biol Chem; 2011 Sep; 286(35):31043-31054. PubMed ID: 21757735
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Partial deletion of the nicotinic cholinergic receptor alpha 4 or beta 2 subunit genes changes the acetylcholine sensitivity of receptor-mediated 86Rb+ efflux in cortex and thalamus and alters relative expression of alpha 4 and beta 2 subunits.
    Gotti C; Moretti M; Meinerz NM; Clementi F; Gaimarri A; Collins AC; Marks MJ
    Mol Pharmacol; 2008 Jun; 73(6):1796-807. PubMed ID: 18337473
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 5-I A-85380 and TC-2559 differentially activate heterologously expressed alpha4beta2 nicotinic receptors.
    Zwart R; Broad LM; Xi Q; Lee M; Moroni M; Bermudez I; Sher E
    Eur J Pharmacol; 2006 Jun; 539(1-2):10-7. PubMed ID: 16674940
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The nicotinic α5 subunit can replace either an acetylcholine-binding or nonbinding subunit in the α4β2* neuronal nicotinic receptor.
    Jin X; Bermudez I; Steinbach JH
    Mol Pharmacol; 2014 Jan; 85(1):11-7. PubMed ID: 24184962
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of an α3β4 nicotinic acetylcholine receptor subunit concatamer to characterize ganglionic receptor subtypes with specific subunit composition reveals species-specific pharmacologic properties.
    Stokes C; Papke RL
    Neuropharmacology; 2012 Sep; 63(4):538-46. PubMed ID: 22580377
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biophysical and pharmacological characterization of α6-containing nicotinic acetylcholine receptors expressed in HEK293 cells.
    Rasmussen AH; Strøbæk D; Dyhring T; Jensen ML; Peters D; Grunnet M; Timmermann DB; Ahring PK
    Brain Res; 2014 Jan; 1542():1-11. PubMed ID: 24157862
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Probing the non-canonical interface for agonist interaction with an α5 containing nicotinic acetylcholine receptor.
    Marotta CB; Dilworth CN; Lester HA; Dougherty DA
    Neuropharmacology; 2014 Feb; 77():342-9. PubMed ID: 24144909
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Desformylflustrabromine Modulates α4β2 Neuronal Nicotinic Acetylcholine Receptor High- and Low-Sensitivity Isoforms at Allosteric Clefts Containing the β2 Subunit.
    Weltzin MM; Schulte MK
    J Pharmacol Exp Ther; 2015 Aug; 354(2):184-94. PubMed ID: 26025967
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Unraveling the high- and low-sensitivity agonist responses of nicotinic acetylcholine receptors.
    Harpsøe K; Ahring PK; Christensen JK; Jensen ML; Peters D; Balle T
    J Neurosci; 2011 Jul; 31(30):10759-66. PubMed ID: 21795528
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pentameric concatenated (alpha4)(2)(beta2)(3) and (alpha4)(3)(beta2)(2) nicotinic acetylcholine receptors: subunit arrangement determines functional expression.
    Carbone AL; Moroni M; Groot-Kormelink PJ; Bermudez I
    Br J Pharmacol; 2009 Mar; 156(6):970-81. PubMed ID: 19366353
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Menthol Alone Upregulates Midbrain nAChRs, Alters nAChR Subtype Stoichiometry, Alters Dopamine Neuron Firing Frequency, and Prevents Nicotine Reward.
    Henderson BJ; Wall TR; Henley BM; Kim CH; Nichols WA; Moaddel R; Xiao C; Lester HA
    J Neurosci; 2016 Mar; 36(10):2957-74. PubMed ID: 26961950
    [TBL] [Abstract][Full Text] [Related]  

  • 38. AE Succinimide, an Analogue of Methyllycaconitine, When Bound Generates a Nonconducting Conformation of the α4β2 Nicotinic Acetylcholine Receptor.
    Qudah T; Quek GX; Indurthi D; Karim N; Halliday JI; Absalom N; McLeod MD; Chebib M
    ACS Chem Neurosci; 2020 Feb; 11(3):344-355. PubMed ID: 31898891
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The neuronal nicotinic alpha4beta2 receptor has a high maximal probability of being open.
    Li P; Steinbach JH
    Br J Pharmacol; 2010 Aug; 160(8):1906-15. PubMed ID: 20649589
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The additional ACh binding site at the α4(+)/α4(-) interface of the (α4β2)2α4 nicotinic ACh receptor contributes to desensitization.
    Benallegue N; Mazzaferro S; Alcaino C; Bermudez I
    Br J Pharmacol; 2013 Sep; 170(2):304-16. PubMed ID: 23742319
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.